Chinese researchers launch open-source AI system to accelerate rare disease diagnosis
Chinese scientists have developed an artificial intelligence tool that can screen DNA to help identify genetic causes of rare diseases, which often take years to diagnose. The system is open-source and freely available, aiming to shorten the so-called 'diagnostic odyssey' for patients. It analyzes the human genome's three billion base pairs to find hidden mutations.
The system, called OneGenome, merges a genomic foundation model named Genos with advanced language reasoning, enabling it to assess the clinical impact of mutations instead of merely scanning raw DNA. During evaluations, it outperformed general models such as DeepSeek-v4 and conventional gene tools in diagnostic and treatment guidance.
Releasing the framework openly seeks to democratize precision care and shorten the prolonged search for answers experienced by those with rare genetic disorders. By integrating diverse global population data, the developers aim to ensure the tool remains effective across different ethnic backgrounds.
The open-source nature of this AI could significantly ease the burden on patients and families enduring lengthy diagnostic processes. By making advanced genomic interpretation freely available, it may help under-resourced healthcare systems access precision medicine that was previously limited to wealthy institutions. However, its real-world effectiveness will depend on clinical validation and integration into existing medical workflows, potentially reshaping how genetic disorders are identified and treated globally.